Novel HIV-1 Integrase Inhibitors Derived from Quinolone Antibiotics
- 15 February 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 49 (5), 1506-1508
- https://doi.org/10.1021/jm0600139
Abstract
The viral enzyme integrase is essential for the replication of human immunodeficiency virus type 1 (HIV-1) and represents a remaining target for antiretroviral drugs. Here, we describe the modification of a quinolone antibiotic to produce the novel integrase inhibitor JTK-303 (GS 9137) that blocks strand transfer by the viral enzyme. It shares the core structure of quinolone antibiotics, exhibits an IC50 of 7.2 nM in the strand transfer assay, and shows an EC50 of 0.9 nM in an acute HIV-1 infection assay.Keywords
This publication has 14 references indexed in Scilit:
- Integrase inhibitors to treat HIV/AidsNature Reviews Drug Discovery, 2005
- Design and Synthesis of Novel Indole β-Diketo Acid Derivatives as HIV-1 Integrase InhibitorsJournal of Medicinal Chemistry, 2004
- A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integraseProceedings of the National Academy of Sciences, 2004
- Integrase Inhibitors and Cellular Immunity Suppress Retroviral Replication in Rhesus MacaquesScience, 2004
- HIV and AIDS: looking aheadNature Medicine, 2003
- HIV Integrase, a Brief Overview from Chemistry to TherapeuticsJournal of Biological Chemistry, 2001
- HIV chemotherapyNature, 2001
- A novel assay for the DNA strand-transfer reaction of HIV-1 integraseNucleic Acids Research, 1994
- Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compoundsJournal of Virological Methods, 1988
- The Synthesis of Certain Substituted Quinolines and 5,6-BenzoquinolinesJournal of the American Chemical Society, 1939